Shareholder pressure is building to such a high level in LLY that he won't be able to avoid listening. Also, the Amylin news really hit them hard. They're going to have to make a big move soon or the CEO is gone. But Lilly is just one of many large pharmas with serious patent problems. BMS is another company that could easily make a run at INCY.